# EDGAR Filing Document

**Accession Number:** 0001610820
**File Stem:** 0001641172-25-015610
**Filing Date:** 2025-6
**Character Count:** 2000
**Document Hash:** 415f10aceeff91192292e0c99df08d2e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-015610.hdr.sgml**: 20250812

**ACCESSION NUMBER**: 0001641172-25-015610

**CONFORMED SUBMISSION TYPE**: DRSLTR

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250618

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BriaCell Therapeutics Corp.
- **CENTRAL INDEX KEY:** 0001610820
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** DRSLTR

**BUSINESS ADDRESS:**
- **STREET 1:** 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
- **CITY:** WEST VANCOUVER
- **STATE:** A1
- **ZIP:** V7T 2X1
- **BUSINESS PHONE:** (604) 921-1810

**MAIL ADDRESS:**
- **STREET 1:** 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
- **CITY:** WEST VANCOUVER
- **STATE:** A1
- **ZIP:** V7T 2X1

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ansell Capital Corp.
- **DATE OF NAME CHANGE:** 20140613

June 18, 2025

**VIA EDGAR**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street NE

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **BriaCell Therapeutics Corp. (the "Company")** |
|  | **Draft Registration Statement on Form S-1** |
|  | **Filed June 18, 2025** |

---

Ladies and Gentlemen:

The Company affirms that the above-referenced Registration Statement on Form S-1 (the "Registration Statement") confidentially submitted on June 18, 2025, and the subsequent public filing of the Registration Statement shall be publicly available on the EDGAR system at least two business days prior to any requested effective time and date.

If you have any questions regarding this filing, please do not hesitate to contact our counsel Jeff Cahlon, of Sichenzia Ross Ference Carmel LLP at (212) 930-9700.

---

| |
|:---|
| Very truly yours, |
| */s/ William V. Williams* |
| William V. Williams<br>|
| President and Chief Executive Officer |

---